Hostname: page-component-848d4c4894-8kt4b Total loading time: 0 Render date: 2024-07-03T19:39:40.074Z Has data issue: false hasContentIssue false

P0124 - The VADO approach in psychiatric rehabilitation: A randomized controlled trial

Published online by Cambridge University Press:  16 April 2020

A. Gigantesco
Affiliation:
Unit of Mental Health, Italian National Institute of Health, Roma, Italy
P. Morosini
Affiliation:
Unit of Mental Health, Italian National Institute of Health, Roma, Italy
M. Vittorielli
Affiliation:
Psychiatry Rehabilitation Unit, Fatebenefratelli Hospitalization and Care Scientific Institute, Brescia, Italy
R. Pioli
Affiliation:
Psychiatry Rehabilitation Unit, Fatebenefratelli Hospitalization and Care Scientific Institute, Brescia, Italy

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

This study investigated whether a specific planning and evaluation approach called VADO (Skills Assessment and Definition of Goals) resulted in improved personal and social functioning among patients with chronic schizophrenia.

Methods:

A total of 85 patients with chronic schizophrenia were randomly allocated to the VADO-based intervention or to routine care; 78 completed the program. Interventions were carried out in nine Italian day treatment or residential rehabilitation facilities. Assessment at the beginning of the study and at the one-year follow-up included the Personal and Social Performance scale (PSP) and Brief Psychiatric Rating Scale Version 4.0 (BPRS). Clinically significant improvement was defined as an increase of at least 10 points on the PSP or a decrease of at least 20 percent on the BPRS total score.

Results:

At baseline, average PSP scores in the experimental group and in the control group were 33.9±8.1 and 34.0±11.2, respectively. (Possible scores range from 1 to 100, with higher scores indicating better functioning.) At six months, the score improved markedly in the experimental group (40.8±10.9) and minimal change was observed in the control group (35.3±11.6); the difference between groups was significant (difference of 6.9 points compared with 1.3 points; t=2.21, df=81, p<.05). At 12 months, the same trend was observed (difference of 12.0 points compared with 3.5 points), and the difference between groups was both statistically and clinically significant (t=2.99, df=75, p<.01).

Conclusions:

A statistically and clinically significant improvement in functioning was observed among patients treated with the VADO approach.

Type
Poster Session I: Schizophrenia and Psychosis
Copyright
Copyright © European Psychiatric Association 2008
Submit a response

Comments

No Comments have been published for this article.